The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Alzheimer's Disease Market Research Report 2025
Synopsis
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4024.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease.
Report Scope
The Alzheimer's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4024.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease.
Report Scope
The Alzheimer's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer's Disease Market Perspective (2019-2030)
2.2 Alzheimer's Disease Growth Trends by Region
2.2.1 Global Alzheimer's Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer's Disease Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer's Disease Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer's Disease Market Dynamics
2.3.1 Alzheimer's Disease Industry Trends
2.3.2 Alzheimer's Disease Market Drivers
2.3.3 Alzheimer's Disease Market Challenges
2.3.4 Alzheimer's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer's Disease Players by Revenue
3.1.1 Global Top Alzheimer's Disease Players by Revenue (2019-2024)
3.1.2 Global Alzheimer's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer's Disease Revenue
3.4 Global Alzheimer's Disease Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Revenue in 2023
3.5 Alzheimer's Disease Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer's Disease Breakdown Data by Type
4.1 Global Alzheimer's Disease Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer's Disease Forecasted Market Size by Type (2025-2030)
5 Alzheimer's Disease Breakdown Data by Application
5.1 Global Alzheimer's Disease Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer's Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer's Disease Market Size (2019-2030)
6.2 North America Alzheimer's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer's Disease Market Size by Country (2019-2024)
6.4 North America Alzheimer's Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer's Disease Market Size (2019-2030)
7.2 Europe Alzheimer's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer's Disease Market Size by Country (2019-2024)
7.4 Europe Alzheimer's Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer's Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer's Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer's Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer's Disease Market Size (2019-2030)
9.2 Latin America Alzheimer's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer's Disease Market Size by Country (2019-2024)
9.4 Latin America Alzheimer's Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer's Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer's Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer's Disease Introduction
11.1.4 Allergan Revenue in Alzheimer's Disease Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Detail
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer's Disease Introduction
11.2.4 Eisai Revenue in Alzheimer's Disease Business (2019-2024)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer's Disease Introduction
11.3.4 Novartis Revenue in Alzheimer's Disease Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Alzheimer's Disease Introduction
11.4.4 Daiichi Sankyo Revenue in Alzheimer's Disease Business (2019-2024)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Detail
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Alzheimer's Disease Introduction
11.5.4 Merz Pharma Revenue in Alzheimer's Disease Business (2019-2024)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer's Disease Introduction
11.6.4 Pfizer Revenue in Alzheimer's Disease Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Alzheimer's Disease Introduction
11.7.4 Johnson & Johnson Revenue in Alzheimer's Disease Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Alzheimer's Disease Introduction
11.8.4 Lundbeck Revenue in Alzheimer's Disease Business (2019-2024)
11.8.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
